Group, Llc Redmile

ALDR 8,244,896 shares
XERS 3,000,642 shares
FATE 11,216,809 shares
IGMS 3,144,000 shares
APRE 2,268,718 shares
AQXP 4,041,211 shares

The estimated Net Worth of Group, Llc Redmile is at least $615,684,845.92. Group, Llc Redmile owns over 8,244,896 units of Alder Biopharmaceuticals, Inc. stock worth over $94,816,304.00.

Transaction DateCompanySharesTypeOwnedPriceValuePost Value
1st October 2020IGMS - IGM Biosciences, Inc.178Grant/award etc.3,425,989$0.00
4th March 2019ALDR - Alder Biopharmaceuticals, Inc.1,739,130Grant/award etc.8,244,896$11.50$19,999,995.00$94,816,304.00
19th February 2019TCRR - TCR2 Therapeutics, Inc.807,256Conversion of derivative807,256$0.00
19th February 2019XERS - Xeris Pharmaceuticals, Inc.588,000Open or private purchase3,000,642$10.00$5,880,000.00$30,006,420.00
23rd April 2019HOOK - HOOKIPA Pharma Inc.999,322Conversion of derivative999,322$0.00
24th June 2019AKRO - Akero Therapeutics, Inc.743,802Conversion of derivative743,802$0.00
24th June 2019BCEL - Atreca, Inc.715,306Conversion of derivative715,306$0.00
21st June 2019STOK - Stoke Therapeutics, Inc.671,808Conversion of derivative671,808$0.00
16th September 2019FATE - Fate Therapeutics, Inc.857,143Open or private purchase11,216,809$17.50$15,000,002.50$196,294,157.50
20th September 2019IGMS - IGM Biosciences, Inc.3,144,000Grant/award etc.3,144,000$16.00$50,304,000.00$50,304,000.00
7th October 2019APRE - Aprea Therapeutics, Inc.400,000Open or private purchase2,268,718$15.00$6,000,000.00$34,030,770.00
7th October 2019APRE - Aprea Therapeutics, Inc.1,868,718Conversion of derivative1,868,718$0.00
22nd October 2019ALDR - Alder Biopharmaceuticals, Inc.8,244,896Disposition due to a tender of shares in a change of control transaction0$0.00
29th October 2019CABA - Cabaletta Bio, Inc.696,378Conversion of derivative696,378$0.00
1st April 2020IGMS - IGM Biosciences, Inc.178Grant/award etc.3,144,178$0.00
2nd April 2020AQXP - Aquinox Pharmaceuticals, Inc.100Open or private sale4,041,211$11.82$1,182.00$47,767,114.02
2nd April 2020AQXP - Aquinox Pharmaceuticals, Inc.9,734Open or private sale4,041,311$11.30$110,032.16$45,682,575.41
2nd April 2020AQXP - Aquinox Pharmaceuticals, Inc.1,000Open or private purchase4,051,045$11.85$11,850.60$48,007,313.88
2nd April 2020AQXP - Aquinox Pharmaceuticals, Inc.38,300Open or private purchase4,050,045$11.36$435,107.15$46,010,536.22
1st April 2020AQXP - Aquinox Pharmaceuticals, Inc.200Open or private sale4,011,745$11.87$2,373.00$47,599,354.43
1st April 2020AQXP - Aquinox Pharmaceuticals, Inc.9,634Open or private sale4,011,945$11.06$106,567.45$44,378,530.81
1st April 2020AQXP - Aquinox Pharmaceuticals, Inc.9,000Open or private purchase4,021,579$11.65$104,865.30$46,858,232.03
1st April 2020AQXP - Aquinox Pharmaceuticals, Inc.33,500Open or private purchase4,012,579$10.95$366,764.70$43,930,517.41
31st March 2020AQXP - Aquinox Pharmaceuticals, Inc.7,500Open or private purchase3,979,079$10.71$80,309.25$42,607,580.02
31st March 2020AQXP - Aquinox Pharmaceuticals, Inc.22,500Open or private purchase3,971,579$10.18$229,079.25$40,435,837.27
30th March 2020AQXP - Aquinox Pharmaceuticals, Inc.2,700Open or private purchase3,949,079$10.27$27,740.88$40,574,417.28
30th March 2020AQXP - Aquinox Pharmaceuticals, Inc.29,800Open or private purchase3,946,379$9.91$295,169.00$39,088,884.00
27th March 2020AQXP - Aquinox Pharmaceuticals, Inc.50,000Open or private purchase3,916,579$9.21$460,395.00$36,063,467.77
5th June 2020PLRX - PLIANT THERAPEUTICS, INC.1,910,657Conversion of derivative1,910,657$0.00
11th June 2020FATE - Fate Therapeutics, Inc.1,412,928Open or private purchase12,629,737$28.31$39,999,991.68$357,547,854.47
23rd June 2020RPTX - Repare Therapeutics Inc.1,586,174Conversion of derivative1,586,174$0.00
1st July 2020IGMS - IGM Biosciences, Inc.178Grant/award etc.3,144,356$0.00
28th July 2020ANNX - Annexon, Inc.1,596,222Conversion of derivative1,596,222$0.00
3rd August 2020ALVR - Allovir, Inc.823,371Conversion of derivative823,371$0.00
3rd September 2020IGMS - IGM Biosciences, Inc.74,253Open or private purchase3,281,005$48.69$3,615,207.79$159,744,587.14
2nd September 2020IGMS - IGM Biosciences, Inc.19,173Open or private purchase3,206,752$46.76$896,592.75$149,958,305.80
2nd September 2020IGMS - IGM Biosciences, Inc.1,464Open or private purchase3,187,579$45.54$66,674.22$145,170,316.61
1st September 2020IGMS - IGM Biosciences, Inc.41,759Open or private purchase3,186,115$44.84$1,872,327.40$142,854,245.20
9th September 2020IGMS - IGM Biosciences, Inc.8,650Open or private purchase3,425,811$51.85$448,523.26$177,636,522.30
9th September 2020IGMS - IGM Biosciences, Inc.14,610Open or private purchase3,417,161$52.96$773,811.35$180,988,223.78
8th September 2020IGMS - IGM Biosciences, Inc.47,113Open or private purchase3,402,551$49.91$2,351,504.06$169,828,125.51
4th September 2020IGMS - IGM Biosciences, Inc.74,433Open or private purchase3,355,438$50.28$3,742,186.06$168,697,665.34